European Primary Care Cardiovascular Society

Time-restricted eating showed no difference in weight loss or metabolic markers

Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity - The TREAT Randomized Clinical Trial

Literature - Lowe DA, Wu N, Rohdin-Bibby L, et al. - JAMA Intern Med 2020, doi:10.1001/jamainternmed.2020.4153

Introduction and methods

Intermittent fasting is defined by eating windows and specified periods of fasting (>12 hours and up to 48 hours, or more). Intermittent fasting is getting more attention as a simple method for weight loss. However, this method is untested or undertested in humans [1]. Time restricted eating (TRE) is a subtype of intermittent fasting and has consistent fasting and eating windows within a cycle of 24 hours.

Murine studies have shown beneficial effects of TRE [2,3] and small human studies suggested reduced calorie intake and decreased body weight and/or fat mass with TRE in individuals with overweight or obesity [4-8].

In this randomized clinical trial, the effect of TRE on weight and metabolic outcomes was examined in patients with overweight or obesity. 116 Patients were randomized to 8-hour TRE (16 hours fast:8 hours eat) or a standard 3-meals-per-day-diet (consistent meal timing, CMT) and were followed for 12 weeks. Participants were provided a Bluetooth weight scale, which was connected through a study app. The study interventions included recommendation to the timing of food intake (not for calorie intake or physical activity. 50 Study participants who lived close to San Francisco underwent extensive in-person metabolic testing. Participants had a mean age of 46.5 (SE: 10.5) years and mean weight was 99.2 (SD: 16.0) kg.

Main results

Conclusion

No effect of TRE on weight loss was observed in a randomized trial of 116 patients when compared to a standard 3-meals-per-day-diet. Also, no differences were observed for metabolic markers between the two groups. The study showed a decrease in ALM in the TRE group, raising caution about the potential effect of TRE.

References

Show references

Find this article online at JAMA Internal Medicine

Share this page with your colleagues and friends: